Measurement of chromosomal aberrations, sister chromatid exchange, hprt mutations, and DNA adducts in peripheral lymphocytes of human populations at increased risk for cancer
- 1 October 1993
- journal article
- review article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 101 (suppl 3) , 121-125
- https://doi.org/10.1289/ehp.93101s3121
Abstract
Using a multidisciplinary approach, we have measured various indicators of DNA damage in peripheral lymphocytes of human populations potentially at increased risk for cancer. Sister chromatid exchanges (SCE) and polycyclic aromatic hydrocarbon (PAH)-DNA adducts were evaluated in a group of firefighters; chromosomal aberrations and hprt mutations were evaluated in a group of cancer patients undergoing radioimmunoglobulin therapy (RIT); SCE and acrolein-modified DNA were measured in cancer chemotherapy patients and in pharmacists preparing chemotherapy prescriptions; and SCE and PAH-DNA adducts are being measured in U.S. army troops stationed in Kuwait. Our results indicate that both SCE and PAH-DNA adduct levels were not elevated in firefighters, but that other factors such as smoking status and race were risk factors for increased SCE and PAH-DNA adducts. RIT was found to increase background rates of chromosome-type aberrations and frequencies of hprt mutations and there was a strong correlation between levels of therapy-induced chromosome damage sustained in vivo and in vitro sensitivity to radiation-induced chromosome damage. Peripheral blood lymphocytes of cancer patients treated with cyclophosphamide showed higher levels of SCE and had a higher incidence of acrolein adducts in DNA. Lymphocytes from pharmacists preparing antineoplastic drugs were found to acquire increased in vitro sensitivity to SCE induction by phosphoramide mustard with increased lifetime duration of drug handling. A prospective, longitudinal study was performed to identify environmental factors that modulate genetic damage in breast cancer patients. Women with benign breast masses and no apparent disease served as controls. Mutant frequency, cloning efficiency, and chromosomal aberration frequency did not differ significantly among the three groups.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 9 references indexed in Scilit:
- Baseline and phosphoramide mustard-induced sister-chromatid exchanges in pharmacists handling anti-cancer drugsMutation Research/Genetic Toxicology, 1992
- Factors influencing mutation at the hprt locus in T‐lymphocytes: Studies in normal women and women with benign and malignant breast massesEnvironmental and Molecular Mutagenesis, 1992
- In vivo ionizing irradiations produce deletions in the hprt gene of human T-lymphocytesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Evidence for acrolein-modified DNA in peripheral blood leukocytes of cancer patients treated with cyclophosphamideMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Molecular analysis of in vivo hprt mutations in human T lymphocytes. V. Effects of total body irradiation secondary to radioimmunoglobulin therapy (RIT)Mutagenesis, 1990
- Baseline and phosphoramide mustard-induced sister-chromatid exchanges in cancer patients treated with cyclophosphamideMutation Research/Genetic Toxicology, 1990
- Increased chromosomal radiosensitivity in patients undergoing radioimmunoglobulin therapyMutation Research Letters, 1989
- BIOLOGICAL MONITORING OF FIRE FIGHTERS - SISTER CHROMATID EXCHANGE AND POLYCYCLIC AROMATIC HYDROCARBON-DNA ADDUCTS IN PERIPHERAL-BLOOD CELLS1989
- Interlaboratory comparison of antisera and immunoassays for benzo[a] pyrene-diol-epoxide-I-modified DNACarcinogenesis: Integrative Cancer Research, 1988